PT - JOURNAL ARTICLE AU - Duani, Helena AU - Cabral, Máderson Alvares de Souza AU - Machado, Carla Jorge AU - Fonseca, Thalyta Nogueira AU - Marcolino, Milena Soriano AU - Nobre, Vandack Alencar AU - Ravetti, Cecilia Gómez AU - Vassallo, Paula Frizera AU - Tupinambás, Unaí TI - Assessing the Role of Red Blood Cell Distribution Width in Hospital Mortality Among Elderly and Non-Elderly COVID-19 Patients: A Prospective Study in a Brazilian University Hospital AID - 10.1101/2024.08.05.24311491 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.05.24311491 4099 - http://medrxiv.org/content/early/2024/08/05/2024.08.05.24311491.short 4100 - http://medrxiv.org/content/early/2024/08/05/2024.08.05.24311491.full AB - This study investigated the role of red blood cell distribution width (RDW) as a risk factor for hospital mortality in COVID-19 patients at a public hospital in Minas Gerais, Brazil. The study included 161 patients over 16 years old hospitalized between May and October 2020, with 39 (24.2%) deaths. Key mortality risk factors identified were age over 70 years (RR=2.78; p<0.001), male sex (RR=2.28; p=0.005), cardiovascular disease (RR=1.8; p=0.044), and abnormal chest X-ray upon admission (RR=3.07; p=0.022). Although high RDW at admission did not significantly predict mortality (31.1% vs 21.7%; RR=1.43; p=0.413), it was linked to higher mortality in patients aged 70 and over (66.7% vs 33.3%; RR=2; p=0.029). High RDW during hospitalization was a strong mortality factor for the entire cohort (41.1% vs 10.2%; RR=4.03; p<0.001) and at any time during the stay (39.7% vs 9.6%; RR=4.14; p<0.001). The Cox model analysis showed that age >70 years (HR=4.8; p<0.001), white race (HR=3.2; p=0.018), need for invasive ventilation (HR=3.8; p=0.001), and abnormal chest X-ray (HR=3.5; p=0.044) were significant risk factors, but RDW was not associated with mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was conducted in accordance with the ethical principles established in the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Review Board of UFMG, under the approval number 30437020.9.3001.5124. All participants were informed about the study's objectives, procedures, potential risks, and benefits, and they signed a written informed consent form prior to participation. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCOVID-19Coronavirus Disease 2019CTcomputed tomographyHC-UFMGHospital das Clínicas of the Universidade Federal de Minas GeraisHRHazard RatioICUIntensive Care UnitMCVmean corpuscular volumeMVmechanical ventilationPNADNational Household Sample Survey, in Portuguese: Pesquisa Nacional por Amostra de DomicíliosPTE/DVTthromboembolism/deep venous thrombosisRDWRed blood cell distribution widthRRRisk RatioRT-PCRreal-time polymerase chain reactionSARSSevere Acute Respiratory SyndromeSDstandard deviationSUSBrazilian Unified Health System